Terms: = Gastric cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
284 results:
1. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract] [Full Text] [Related]
2. Discrepant effect of high-density lipoprotein cholesterol on esophageal and gastric cancer risk in a nationwide cohort.
Nam SY; Jo J; Jeon SW
Gastric Cancer; 2024 May; 27(3):451-460. PubMed ID: 38416240
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Extended Fixation on Advanced gastric cancer HER2 Status Assessment Using IHC and FISH.
Kondo J; Yoshino S; Iida M; Takeda S; Nakashima C; Watanabe Y; Nishiyama M; Tokumitsu Y; Shindo Y; Nishimura T; Suzuki N; Hoshii Y; Itoh H; Nagano H
Anticancer Res; 2024 Feb; 44(2):621-630. PubMed ID: 38307565
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
5. Impact of the Helicobacter pylori Oncoprotein CagA in gastric Carcinogenesis.
Hatakeyama M
Curr Top Microbiol Immunol; 2023; 444():239-257. PubMed ID: 38231221
[TBL] [Abstract] [Full Text] [Related]
6. Helicobacter pylori-Induced Host Cell DNA Damage and Genetics of gastric cancer Development.
Backert S; Linz B; Tegtmeyer N
Curr Top Microbiol Immunol; 2023; 444():185-206. PubMed ID: 38231219
[TBL] [Abstract] [Full Text] [Related]
7. Ailanthone synergizes with PARP1 inhibitor in tumour growth inhibition through crosstalk of DNA repair pathways in gastric cancer.
Wang C; Yi T; Li X; Cui J; Li B; Qin Y; Tang S; Zhang J
J Cell Mol Med; 2024 Jan; 28(2):e18033. PubMed ID: 38009603
[TBL] [Abstract] [Full Text] [Related]
8. STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.
Zhou J; Nie RC; He ZP; Cai XX; Chen JW; Lin WP; Yin YX; Xiang ZC; Zhu TC; Xie JJ; Zhang YC; Wang X; Lin P; Xie D; D'Andrea AD; Cai MY
Adv Sci (Weinh); 2023 Dec; 10(36):e2302494. PubMed ID: 37985839
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death.
Stålhammar G
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37972025
[TBL] [Abstract] [Full Text] [Related]
10. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria.
Ding D; Guo G; Cui L; Jia G; Wang X; Zhang M; Tian S; Zheng L; Liu Y; Hu Y; Xuan G; Yang J; Yang C; Sun R; Deng J; Guo C; Chen Y; Shang Y; Han Y
Hepatol Int; 2024 Feb; 18(1):206-215. PubMed ID: 37725332
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
Lv Y; Bai W; Zhu X; Xue H; Zhao J; Zhuge Y; Sun J; Zhang C; Ding P; Jiang Z; Zhu X; Ren W; Li Y; Zhang K; Zhang W; Li K; Wang Z; Luo B; Li X; Yang Z; Guo W; Xia D; Xie H; Pan Y; Yin Z; Fan D; Han G
Hepatology; 2024 Jan; 79(1):118-134. PubMed ID: 37594323
[TBL] [Abstract] [Full Text] [Related]
13. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
[No Abstract] [Full Text] [Related]
14. Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence.
Usui Y; Momozawa Y
Cancer Sci; 2023 Oct; 114(10):3816-3824. PubMed ID: 37530079
[TBL] [Abstract] [Full Text] [Related]
15. Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.
Ponti G; De Angelis C; Ponti R; Pongetti L; Losi L; Sticchi A; Tomasi A; Ozben T
Crit Rev Clin Lab Sci; 2023 Dec; 60(8):640-650. PubMed ID: 37455374
[TBL] [Abstract] [Full Text] [Related]
16. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
17. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group.
Loong HH; Shimizu T; Prawira A; Tan AC; Tran B; Day D; Tan DSP; Ting FIL; Chiu JW; Hui M; Wilson MK; Prasongsook N; Koyama T; Reungwetwattana T; Tan TJ; Heong V; Voon PJ; Park S; Tan IB; Chan SL; Tan DSW
ESMO Open; 2023 Aug; 8(4):101586. PubMed ID: 37356359
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenic structural aberration landscape in gastric cancer genomes.
Saito-Adachi M; Hama N; Totoki Y; Nakamura H; Arai Y; Hosoda F; Rokutan H; Yachida S; Kato M; Fukagawa A; Shibata T
Nat Commun; 2023 Jun; 14(1):3688. PubMed ID: 37349325
[TBL] [Abstract] [Full Text] [Related]
19. Hereditary gastric cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.
Calvello M; Marabelli M; Gandini S; Marino E; Bernard L; Dal Molin M; Di Cola G; Zanzottera C; Corso G; Fazio N; Gervaso L; Fumagalli Romario U; Barberis M; Guerrieri-Gonzaga A; Bertario L; Serrano D; Bonanni B
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239438
[TBL] [Abstract] [Full Text] [Related]
20. Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for brca1/2 variant carriers in Japan.
Ueki A; Yoshida R; Kosaka T; Matsubayashi H
J Hum Genet; 2023 Aug; 68(8):517-526. PubMed ID: 37088789
[TBL] [Abstract] [Full Text] [Related]
[Next]
